Related Experiment Video

Updated: Jun 24, 2025

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
08:25

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment

Published on: December 6, 2024

343

Asthma control associated with anxiety and depression in asthmatic children following post-acute COVID-19

Tung-Ming Chang1,2,3, Yun Chen2, Kuender D Yang4,5

  • 1Department of Pediatrics, Changhua Christian Children's Hospital, Changhua, Taiwan.

Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|June 14, 2024
PubMed

Insights

Pediatric asthma patients with COVID-19 showed increased anxiety and depression. Poor asthma control and high exhaled nitric oxide (FENO) levels were linked to worse mental health outcomes.

Area of Science:

  • Pediatric pulmonology and mental health research.
  • Investigating the impact of viral infections on chronic respiratory conditions.

Background:

  • Poorly controlled asthma can negatively impact mental well-being.
  • The study explores the link between inadequate asthma control, exhaled nitric oxide (FENO) levels, and mental health in pediatric asthma patients with COVID-19.

Purpose of the Study:

  • To investigate the correlation between inadequate asthma control, FENO levels, and anxiety and depression in pediatric asthma patients who have contracted COVID-19.
  • To assess the mental health status of asthmatic children post-COVID-19 infection.

Main Methods:

  • A prospective case-control study involving 520 asthmatic children (8-15 years).
  • Included 336 patients with COVID-19 and 184 age-matched controls without COVID-19.
  • Assessed anxiety and depression using SCARED and PHQ-9, correlated with Childhood Asthma Control Test (C-ACT) and FENO levels one month post-infection.

Main Results:

  • Asthmatic children with COVID-19 showed significantly increased anxiety and depression scores (p < .05).
  • Poor asthma control was associated with the highest anxiety and depression scores in children with COVID-19 (p < .01).
  • Reduced C-ACT scores and elevated FENO levels were significant risk factors for anxiety and depression in these children (p < .05).

Conclusions:

  • Healthcare professionals must closely monitor asthma control in children during the COVID-19 pandemic.
  • Proactive management of asthma control is crucial to mitigate risks of depression and anxiety in pediatric patients.
  • Early intervention for asthma control can help prevent adverse mental health outcomes in children affected by COVID-19.
Abstract

Keywords:
allergic asthmaanxietyasthma controldepressionfractional exhaled nitric oxide

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.9K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

3.4K

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.0K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
384
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K